These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 31781610)
1. The application of microwaves in axillary hyperhidrosis: Curative effect observation of a pathological examination over 1 year. Tan Y; Huang W; Liu J; Duan Z; He X; Li Q; Yang Z J Cosmet Dermatol; 2024 Jan; 23(1):134-140. PubMed ID: 37547985 [TBL] [Abstract][Full Text] [Related]
2. Assessing Botulinum Toxin Effectiveness and Quality of Life in Axillary Hyperhidrosis: A One-Year Prospective Study. Castiglione L; Murariu M; Boeriu E; Enatescu I Diseases; 2024 Jan; 12(1):. PubMed ID: 38248366 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of 5% sofpironium bromide gel in Duchenne muscular dystrophy with palmoplantar hyperhidrosis: A retrospective case study. Funato M; Iwata R; Iimoto M J Dermatol; 2024 Jan; 51(1):135-139. PubMed ID: 37795807 [TBL] [Abstract][Full Text] [Related]
4. Internalized stigma, disease severity, quality of life, anxiety and depression in axillary hyperhidrosis. Gökşin Ş; İmren IG Ann Dermatol Venereol; 2024 Sep; 151(3):103291. PubMed ID: 39013257 [TBL] [Abstract][Full Text] [Related]
6. The reliability and validity of a developed anxiety scale specific to primary focal hyperhidrosis symptoms. Ogawa S; Tayama J; Murota H; Kobayashi M; Kinoshita H; Nakamichi S Biopsychosoc Med; 2024 Jun; 18(1):14. PubMed ID: 38835082 [TBL] [Abstract][Full Text] [Related]
7. Primary Hyperhidrosis in Children-A Retrospective Study and a Short Review. Nastase F; Verenca MC; Niculet E; Radaschin DS; Busila C; Vasile CI; Tatu AL Life (Basel); 2024 May; 14(5):. PubMed ID: 38792665 [TBL] [Abstract][Full Text] [Related]
9. Treatment of Primary Axillary Hyperhidrosis with Two Doses of Botulinum Toxin A-Observational Study. Antón Andrés MJ; Candau Pérez ED; Bermejo de la Fuente MP Toxins (Basel); 2024 Jul; 16(7):. PubMed ID: 39057960 [TBL] [Abstract][Full Text] [Related]
10. Measurement properties of patient-reported outcome measures (PROMs) in hyperhidrosis: a systematic review. Gabes M; Knüttel H; Kann G; Tischer C; Apfelbacher CJ Qual Life Res; 2022 Mar; 31(3):671-686. PubMed ID: 34327635 [TBL] [Abstract][Full Text] [Related]
11. Lumbar Sympathetic Nerve Modulation Using Absolute Ethanol for the Treatment of Primary Lower-Extremity Hyperhidrosis: A Dose-Effect Pilot Study. Liu M; Ni H; Tao J; Xie K Med Sci Monit; 2021 Jan; 27():e928209. PubMed ID: 33434188 [TBL] [Abstract][Full Text] [Related]
12. Impact of microwave thermolysis energy levels on patient-reported outcomes for axillary hyperhidrosis and osmidrosis. Grove GL; Togsverd-Bo K; Schwensen JFB; Andersson NW; Nissen CV; Zachariae C; Haedersdal M Lasers Surg Med; 2023 Jan; 55(1):105-115. PubMed ID: 36229952 [TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of a microwave device for treating axillary hyperhidrosis. Hong HC; Lupin M; O'Shaughnessy KF Dermatol Surg; 2012 May; 38(5):728-35. PubMed ID: 22452511 [TBL] [Abstract][Full Text] [Related]
14. [Management of hyperhidrosis]. Maillard H; Lecouflet M Ann Dermatol Venereol; 2015 Apr; 142(4):252-61. PubMed ID: 25697587 [TBL] [Abstract][Full Text] [Related]
15. Current treatments for axillary hyperhidrosis. Fitzgerald E; Feeley TM; Tierney S Surgeon; 2004 Dec; 2(6):311-4, 360. PubMed ID: 15712569 [TBL] [Abstract][Full Text] [Related]
16. Effects of Direct Current Administration on Hyperhidrosis Disease Severity Scale in Patients with Axillary Hyperhidrosis. Şener S; Karakoç Y Biomed Res Int; 2019; 2019():3232015. PubMed ID: 31781610 [TBL] [Abstract][Full Text] [Related]
17. Fractionated microneedle radiofrequency for treatment of primary axillary hyperhidrosis: A sham control study. Fatemi Naeini F; Abtahi-Naeini B; Pourazizi M; Nilforoushzadeh MA; Mirmohammadkhani M Australas J Dermatol; 2015 Nov; 56(4):279-84. PubMed ID: 25496000 [TBL] [Abstract][Full Text] [Related]